Tel Aviv, Israel

Shimon Slavin

This inventor holds 1 USPTO granted patent and 4 published patent applications and 4 EPO patents. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shimon Slavin. Retrieved from https://idiyas.com/inventor/shimon-slavin-by2a0ekd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shimon Slavin - Innovator in Cancer Treatment

Introduction

Shimon Slavin is an inventor based in Tel Aviv, Israel. He has made significant contributions to the field of medical research, particularly in the area of cancer treatment. Although he currently holds no granted patents, his work is noteworthy for its potential impact on healthcare.

Latest Patent Applications

Shimon Slavin's latest patent applications include:

1. **Use of a Birnavirus Alone or in Combination Therapy for the Treatment of Cancer** - This invention relates to a birnavirus for use in the treatment or prevention of cancer. It also includes a combination comprising at least one birnavirus and at least one further active agent for the same purpose. Furthermore, it describes a pharmaceutical composition comprising the birnavirus or the combination for use in cancer treatment or prevention.

2. **Use of a Birnavirus Alone or in Combination Therapy for the Treatment of a Disease Caused by a Nidovirus** - This application focuses on a birnavirus for treating a disease caused by a nidovirus. It also discusses a combination of at least one birnavirus and at least one further active agent for this treatment. Additionally, it outlines a pharmaceutical composition for the same purpose.

Conclusion

Shimon Slavin's innovative work in the field of cancer treatment highlights his commitment to advancing medical research. His latest patent applications reflect his ongoing efforts to develop effective therapies for serious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…